Genius Sports Limited Ordinary Shares GENI 深 沪
等待开盘 09-23 09:30:00 美东时间
12.79
0.000
0.00%
华盛通- 最 高12.81
- 今 开12.75
- 成交量 201.57万股
- 最 低 12.56
- 昨 收 12.79
- 总市值 30.31亿
- 52周最高 13.7296
- 市盈率 静 --
- 换手率 0.85%
- 52周最低 6.72
- 委 比 -23.54%
- 总股本 2.37亿
- 历史最高 25.18
- 量 比 0.57
- 振 幅 1.95%
- 历史最低 2.20
- 每 手 1
- 风险率 0.95%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多What Does the Market Think About Genius Sports?
Genius Sports's (NYSE:GENI) short interest as a percent of float has fallen 7.4...
09-22 23:00
GENinCode Plc Observes Unexpected Share Price Movement Amid Ongoing FDA Discussions
GENinCode UK Ltd. ( ($GB:GENI) ) has issued an announcement. GENinCode Plc has ...
09-17 17:47
Genius Group executes buyback of one million shares, increases company shares in book entry to 60.3%
Genius Group Limited repurchased one million shares at an average of $0.90 per share between August 28 and September 11, 2025. This is the third buyback since July 2025, bringing total repurchases to three million shares (21% of the approved 20%). CEO Roger Hamilton received restricted shares after the company's market cap reached $100 million, a milestone under a 10-step plan targeting $1 billion by 2030. Another 4.2 million shares were issued t...
09-15 12:00
美股大行评级 | 潜在涨幅280.95%！HC Wainwright & Co.上调Immix Biopharma目标价至8美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从7美元升至8美元；Maxim Group：上调CNS Pharma评级至"买入"，目标价20美元
09-15 11:13
美股大行评级 | 最高400美元！大行纷纷连夜上调甲骨文目标价；新思科技则惨遭多家大行下调目标价
今日重点评级关注：瑞银：上调Gossamer Bio评级至"买入"，目标价从1.25美元升至9美元；Canaccord Genuity：维持Corcept Therapeutics"买入"评级，目标价从137美元升至140美元
09-11 10:06
UBS Maintains Neutral on Genius Sports, Raises Price Target to $13
UBS analyst Robin Farley maintains Genius Sports (NYSE:GENI) with a Neutral and raises the price target from $11 to $13.
09-10 21:41
Figma(FIG.US)大跌20%后，“木头姐”抄底买入10万股
凯西·伍德旗下的投资管理公司Ark Invest趁 Figma 股价下跌之际购入了该股票，其股价已下跌约 20%。
09-05 19:54
Deep Dive Into Genius Sports Stock: Analyst Perspectives (13 Ratings)
During the last three months, 13 analysts shared their evaluations of Genius Sp...
09-04 03:01
JMP Securities Maintains Market Outperform on Genius Sports, Raises Price Target to $15
JMP Securities analyst Jordan Bender maintains Genius Sports (NYSE:GENI) with a Market Outperform and raises the price target from $13 to $15.
09-03 21:22
2025年中国核技术应用行业产值、市场结构及重点企业分析
（来源：华经产业研究院） 核技术一般可分为核武器技术、动力核技术、非动力军用核技术和非动力民用核技术。核技术应用，又称同位素与辐射技术应用，一般指非动力民用核...
08-31 11:10
